SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : World Heart Corp - WHRT and TSE/WHT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: W. Randy Gast who wrote (433)6/10/2000 4:56:00 PM
From: William Marsh   of 500
 
Yes it is in Ottawa. Here's the info:

I am particularly interested in the whys and wherefores on the Novacor purchase.

Thank you very much.

Bill

WORLD HEART CORP ("WHT-T;WHRTF-Q") - Media Advisory - To Hold Annual and
Special Meeting of Shareholders

WORLD HEART CORPORATION

TO HOLD

ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

DATE:

Monday June 12, 2000

Time:

16:00 hrs (4:00 p.m.) - Meeting begins

17:00 hrs (5:00 p.m.) - Refreshments

Location: The Chateau Laurier Hotel in the Drawing Room

1 Rideau Street

Ottawa, Ontario

Event:

World Heart Corporation (WorldHeart) will hold its Annual and

Special meeting of shareholders. A media question and answer

session will follow the formal portion of the meeting. In

addition, the HEARTSAVERvad(TM) and Novacor LVAS systems will

be on display.

At this meeting WorldHeart executives will review the current

status of the Corporation and its HEARTSAVERvad(TM) product

and discuss future plans, including the acquisition of

Novacor, the Oakland, California based ventricular assist

device operation of Edwards Lifesciences Corporation.

HEARTSAVERvad(TM) is a fully implantable heart assist device

designed to provide long-term support of pulsatile blood flow

to people suffering from heart failure.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext